Arensia Exploratory Medicine

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia3 trials
• Hodgkin lymphoma3 trials
• Ulcerative colitis2 trials
• Acute myeloid leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Myelodysplastic syndromes1 trial
• Prostate cancer1 trial

Phase

• Phase 14 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Janssen Research & Development, LLC3 trials
• Gilead Sciences1 trial
• Sorriso Pharmaceuticals, Inc.1 trial

Running trials

• Enrolling by invitation

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  NCT06788509· Phase 1· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06290934· Phase 2· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Hodgkin lymphoma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis

  NCT06080048· Phase 1· Sorriso Pharmaceuticals, Inc.· Source

• Completed

  A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

  NCT04657224· Phase 1· Janssen Research & Development, LLC· Source

• Completed

  A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

  NCT04210219· Phase 1· Janssen Research & Development, LLC· Source